Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:insulin
|
| gptkbp:activeIngredient |
insulin isophane (NPH)
|
| gptkbp:ATCCode |
A10AC01
|
| gptkbp:availableOn |
gptkb:FlexPen
vial |
| gptkbp:duration |
up to 24 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Novolin N
|
| gptkbp:isHumanInsulin |
true
|
| gptkbp:isIntermediateActingInsulin |
true
|
| gptkbp:isPrescriptionDrugIn |
gptkb:United_States
|
| gptkbp:manufacturer |
gptkb:Novo_Nordisk
|
| gptkbp:onset |
1 to 2 hours
|
| gptkbp:peakAction |
4 to 12 hours
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:shouldNotBeFrozen |
true
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
allergic reactions lipodystrophy |
| gptkbp:storage |
2°C to 8°C (refrigerated)
|
| gptkbp:usedFor |
gptkb:diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:Novolin
|
| gptkbp:bfsLayer |
7
|